Nucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System

Author:

Shrivastava Garima1ORCID,Bakshi Hamid A.2ORCID,Aljabali Alaa A.3ORCID,Mishra Vijay4ORCID,Hakkim Faruck L.5ORCID,Charbe Nitin B.6ORCID,Kesharwani Prashant7ORCID,Chellappan Dinesh K.8ORCID,Dua Kamal9ORCID,Tambuwala Murtaza M.2ORCID

Affiliation:

1. Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, Delhi, Hauz Khas, New Delhi, India

2. SAAD Centre for Pharmacy and Diabetes, School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, County Londonderry BT52 1SA Northern Ireland, United Kingdom

3. Faculty of Pharmacy, Department of Pharmaceutical Sciences, Yarmouk University, Irbid, Jordan

4. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab), India

5. Department of Mathematics and Sciences, College of Arts and Applied Sciences, Dhofar University, Salalah, Oman

6. Departamento de Quimica Organica, Facultad de Quimicay de Farmacia, Pontificia Universidad Catolica de Chile, Av. Vicuña McKenna 4860, Macul, Santiago 7820436, Chile

7. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India

8. Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia

9. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia

Abstract

Background: Nucleus targeted drug delivery provides several opportunities for the treatment of fatal diseases such as cancer. However, the complex nucleocytoplasmic barriers pose significant challenges for delivering a drug directly and efficiently into the nucleus. Aptamers representing singlestranded DNA and RNA qualify as next-generation highly advanced and personalized medicinal agents that successfully inhibit the expression of certain proteins; possess extraordinary gene-expression for manoeuvring the diseased cell's fate with negligible toxicity. In addition, the precisely directed aptamers to the site of action present a tremendous potential to reach the nucleus by escaping the ensuing barriers to exhibit a better drug activity and gene expression. Objective: This review epigrammatically highlights the significance of targeted drug delivery and presents a comprehensive description of the principal barriers faced by the nucleus targeted drug delivery paradigm and ensuing complexities thereof. Eventually, the progress of nucleus targeting with nucleic acid aptamers and success achieved so far have also been reviewed. Method: Systematic literature search was conducted of research published to date in the field of nucleic acid aptamers. Conclusion: The review specifically points out the contribution of individual aptamers as the nucleustargeting agent rather than aptamers in conjugated form.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Overview of carbon nanotubes as drug delivery system;Progress and Prospect of Nanocarriers;2024

2. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer;Molecular Cancer;2023-01-12

3. Galactose engineered nanocarriers: Hopes and hypes in cancer therapy;European Polymer Journal;2023-01

4. Aptamer-functionalized dendrimers for targeted cancer therapy;Aptamers Engineered Nanocarriers for Cancer Therapy;2023

5. Aptamer-functionalized nanoparticles for targeted cancer therapy;Aptamers Engineered Nanocarriers for Cancer Therapy;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3